𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Assessing clinical benefit in the treatment of pancreas cancer: Gemcitabine compared to 5-fluorouracil

✍ Scribed by H. Burris; A.M. Storniolo

Book ID
117663584
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
385 KB
Volume
33
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clinical studies of 5-fluorouracil + pre
Clinical studies of 5-fluorouracil + premarin in the treatment of breast cancer
✍ Taylor, Samuel G. ;Pocock, Stuart J. ;Shnider, Bruce I. ;Colsky, Jacob ;Hall, Th πŸ“‚ Article πŸ“… 1975 πŸ› John Wiley and Sons 🌐 English βš– 413 KB

## Abstract Sixty patients with metastatic or primary inoperable breast cancer not suitable for hormone alteration therapy were blindly randomized between weekly 5‐fluorouracil, intravenously, and daily physiologic doses of conjugated estrogens by mouth against weekly 5‐fluorouracil, intravenously,

Gemcitabine in combination with 5-fluoro
Gemcitabine in combination with 5-fluorouracil with or without folinic acid in the treatment of pancreatic cancer
✍ Helmut Oettle; Hanno Riess πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 102 KB πŸ‘ 1 views

Pancreatic cancer is one of the most frequently reported gastrointestinal tumors and has been reported to have a 5-year survival rate of < 5%. It is most commonly diagnosed at an advanced stage and until recently, the most frequently administered treatment for patients with advanced disease has been